StreetAlpha
Icu Medical Inc · SEC Form 4

ICUI Insider Trading

From SEC Form 432 trades in 2 yearsUpdated Nov 20, 2026

Every open market buy and sale of Icu Medical Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $8.4M sold.

← ICUI stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$8.4M13 sales · 7 insiders
Net−$8.4Mbought minus sold
Planned sales42%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJanFebMarApr2026-05: sold $882KMayJunJul2026-08: sold $4.7MAug2026-09: sold $1.9MSepOct2026-11: sold $471KNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when ICUI insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an ICUI officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every ICUI insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Nov 20, 2026David C. GreenbergDirectorSale883$176.12$156K9,214Nov 20Form 4
Nov 13, 2026Elisha W FinneyDirectorSale1,765$179.00$316K4,871Nov 13Form 4
Sep 3, 2026Virginia Ruth SanzoneVP, General CounselSale plan4,856$168.69$819K14,604Sep 3Form 4
Sep 1, 2026Brian Michael BonnellCFOSale plan6,381$175.00$1.1M56,062Sep 1Form 4
Aug 31, 2026Brian Michael BonnellCFOSale plan9,307$172.79$1.6M62,443Aug 31Form 4
Aug 13, 2026Daniel WoolsonVP, GM-Infusion CapitalSale5,417$181.33$982K17,062Aug 13Form 4
Aug 12, 2026Ben SousaChief Information OfficerSale2,250$178.32$401K3,076Aug 12Form 4
Aug 11, 2026Elisha W FinneyDirectorSale378$182.48$69K4,871Aug 11Form 4
Aug 11, 2026Christian B. VoigtlanderCOOSale8,929$182.93$1.6M37,377Aug 11Form 4
May 22, 2026Daniel WoolsonPresidentSale2,123$132.21$281K22,479May 22Form 4
May 14, 2026Virginia Ruth SanzoneVP, General CounselSale2,447$124.08$304K19,460May 15Form 4
May 12, 2026David C. GreenbergDirectorSale2,424$122.91$298K7,960May 13Form 4
Nov 25, 2025Daniel WoolsonVP, GM-Infusion CapitalSale2,897$152.35$441K11,297Nov 25Form 4
Nov 11, 2025Elisha W FinneyDirectorSale1,285$140.42$180K3,995Nov 12Form 4
Nov 11, 2025Virginia Ruth SanzoneVP, General CounselSale930$142.35$132K5,456Nov 12Form 4
🔒 17 more trades. Create a free account or sign in to see them all.

ICUI insider trading FAQ

Are ICUI insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of ICUI on the open market in 0 trades, and 7 sold $8.4M in 13 trades, 42% of that under pre-arranged trading plans.

When did an ICUI insider last buy shares?

David C. Greenberg (Director) bought 1,200 shares for $152K on Aug 27, 2025, reported on Aug 27, 2025.

When did an ICUI insider last sell shares?

David C. Greenberg (Director) sold 883 shares for $156K on Nov 20, 2026.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice